These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18520068)
41. [11C]-MeJDTic: a novel radioligand for kappa-opioid receptor positron emission tomography imaging. Poisnel G; Oueslati F; Dhilly M; Delamare J; Perrio C; Debruyne D; Barré L Nucl Med Biol; 2008 Jul; 35(5):561-9. PubMed ID: 18589300 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase. Ryu EK; Choe YS; Park EY; Paik JY; Kim YR; Lee KH; Choi Y; Kim SE; Kim BT Nucl Med Biol; 2005 Feb; 32(2):185-91. PubMed ID: 15721764 [TBL] [Abstract][Full Text] [Related]
43. Radiosynthesis of [18F]Lu29-024: a potential PET ligand for brain imaging of the serotonergic 5-HT2 receptor. Sobrio F; Amokhtari M; Gourand F; Dhilly M; Dauphin F; Barré L Bioorg Med Chem; 2000 Oct; 8(10):2511-8. PubMed ID: 11058046 [TBL] [Abstract][Full Text] [Related]
44. Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase. Choe YS; Oh S; Shim I; Naruto S; Chi DY; Kim SE; Lee K; Choi Y; Kim B Nucl Med Biol; 2000 Apr; 27(3):263-7. PubMed ID: 10832083 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor. Seo JW; Chi DY; Dence CS; Welch MJ; Katzenellenbogen JA Nucl Med Biol; 2007 May; 34(4):383-90. PubMed ID: 17499727 [TBL] [Abstract][Full Text] [Related]
46. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. Lan R; Liu Q; Fan P; Lin S; Fernando SR; McCallion D; Pertwee R; Makriyannis A J Med Chem; 1999 Feb; 42(4):769-76. PubMed ID: 10052983 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT). Wuest F; Berndt M; Strobel K; van den Hoff J; Peng X; Neumeyer JL; Bergmann R Bioorg Med Chem; 2007 Jul; 15(13):4511-9. PubMed ID: 17467995 [TBL] [Abstract][Full Text] [Related]
48. Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomography. Khanapur S; Paul S; Shah A; Vatakuti S; Koole MJ; Zijlma R; Dierckx RA; Luurtsema G; Garg P; van Waarde A; Elsinga PH J Med Chem; 2014 Aug; 57(15):6765-80. PubMed ID: 25061687 [TBL] [Abstract][Full Text] [Related]
49. Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase. Musachio JL; Flesher JE; Scheffel UA; Rauseo P; Hilton J; Mathews WB; Ravert HT; Dannals RF; Frost JJ Nucl Med Biol; 2002 Jul; 29(5):547-52. PubMed ID: 12088724 [TBL] [Abstract][Full Text] [Related]
50. In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET. Waterhouse RN; Collier TL Nucl Med Biol; 1997 Feb; 24(2):127-34. PubMed ID: 9089705 [TBL] [Abstract][Full Text] [Related]
51. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor. Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities. Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087 [TBL] [Abstract][Full Text] [Related]
53. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5). Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237 [TBL] [Abstract][Full Text] [Related]
54. Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography. Vasdev N; Natesan S; Galineau L; Garcia A; Stableford WT; McCormick P; Seeman P; Houle S; Wilson AA Synapse; 2006 Sep; 60(4):314-8. PubMed ID: 16786538 [TBL] [Abstract][Full Text] [Related]
55. A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. Lazzari P; Distinto R; Manca I; Baillie G; Murineddu G; Pira M; Falzoi M; Sani M; Morales P; Ross R; Zanda M; Jagerovic N; Pinna GA Eur J Med Chem; 2016 Oct; 121():194-208. PubMed ID: 27240274 [TBL] [Abstract][Full Text] [Related]
56. Radiosynthesis and biodistribution of the S-[18F]fluoroethyl analog of McN5652. Suehiro M; Greenberg JH; Shiue CY; Gonzalez C; Dembowski B; Reivich M Nucl Med Biol; 1996 May; 23(4):407-12. PubMed ID: 8832694 [TBL] [Abstract][Full Text] [Related]
57. Radiosynthesis, rodent biodistribution, and metabolism of 1-deoxy-1-[18F]fluoro-D-fructose. Haradahira T; Tanaka A; Maeda M; Kanazawa Y; Ichiya YI; Masuda K Nucl Med Biol; 1995 Aug; 22(6):719-25. PubMed ID: 8535332 [TBL] [Abstract][Full Text] [Related]
58. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects. Van Laere K; Koole M; Sanabria Bohorquez SM; Goffin K; Guenther I; Belanger MJ; Cote J; Rothenberg P; De Lepeleire I; Grachev ID; Hargreaves RJ; Bormans G; Burns HD J Nucl Med; 2008 Mar; 49(3):439-45. PubMed ID: 18287275 [TBL] [Abstract][Full Text] [Related]